It manages hot flashes, vaginal atrophy, mood, bone density, and cardiovascular markers tied to estrogen status
This personalized approach ensures that patients receive a customized plan that maximizes their chances of success
Javanmard SH, Vaseghi G, Ghasemi A, Rafiee L, Ferns GA, Esfahani HN, Nedaeinia R
cardiovascular: Farxiga USD 7.5B+ Key Peptide Products: Bydureon/Byetta (exenatide legacy GLP-1, divested/wound down), Leuplin (leuprolide partnership Japan), Tezspire (tezepelumab TSLP-targeting biologic
The weight-lowering effects of GLP-1 RAs are mediated through multiple, interrelated mechanisms
Common side effects include nausea, diarrhea, vomiting, constipation, headache, and stomach pain